CROOKE ROSANNE M has a total of 24 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ISIS PHARMACEUTICAL INC, MIRAGEN THERAPEUTICS and SYNVOLUX IP BV.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 10 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks | |
#6 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Climate change mitigation in goods production | |
#5 | Measuring microorganism processes | |
#6 | Enzymes | |
#7 | Sugars | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Crooke Rosanne M | 24 |
#2 | Graham Mark J | 22 |
#3 | Lemonidis Kristina M | 2 |
#4 | Wancewicz Edward | 2 |
#5 | Mah Steven | 2 |
#6 | Yu Zhengrong | 1 |
#7 | Nero Pamela S | 1 |
#8 | Nero Pamela | 1 |
#9 | Graham Mark | 1 |
#10 | Bell Thomas A | 1 |
Publication | Filing date | Title |
---|---|---|
US2006009410A1 | Effects of apolipoprotein B inhibition on gene expression profiles in animals | |
US2005287558A1 | SNPs of apolipoprotein B and modulation of their expression |